Home >
How we work > Product development
|
 |
Product development |
Our client purchased a
new unlicensed product which was the second in a new class to market and in a
therapeutic area unfamiliar to them.
JBM were
briefed to produce a summary of the
available evidence, using clinical trial reports and published clinical trials,
to identify pertinent information for regulatory, medical and marketing
departments.
Steps in the process
carried out by JBM were as follows:
Step 1: Review all
available evidence. The clinical trial reports ran to thousands of pages,
therefore our ability to quickly identify and distil out relevant information
was invaluable to the client.
Step 2: Produce
individual data summaries for each trial using a standard template to enable the
reader to quickly identify the study details, study population, efficacy
variables and results. A conclusion provided a summary of the relevant finding
of the study and study limitations provided an insight
into areas where the study was inadequate. Take home points for each study
identified the key outputs from the study.
Step 3: Produce an
overall clinical data summary, pulling results of all relevant studies together in an easy to read document,
relevant for regulatory, medical and marketing teams.
Outcomes: The materials
are being used across the company to inform and educate staff around the new
product and to inform product licensing and eventual marketing strategy.